2548
CASE REPORT: Soon after initiation of amiodarone HCl (200 mg/day), a 76-year-old man came to us with symptoms of visual "shining," glare, color vision anomalies, and gradually decreased vision.
 a 76-year-old man: Subject; 76-year-old: Subject.Age; man: Subject.Gender; symptoms of visual "shining," glare, color vision anomalies, and gradually decreased vision: Effect; amiodarone HCl: Treatment; amiodarone HCl: Treatment.Drug; (200 mg: Treatment.Dosage; day: Treatment.Freq
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 76-year-old man: Subject; 76-year-old: Subject.Age; man: Subject.Gender; symptoms of visual "shining," glare, color vision anomalies, and gradually decreased vision: Effect; amiodarone HCl: Treatment; amiodarone HCl: Treatment.Drug; (200 mg: Treatment.Dosage; day: Treatment.Freq